Er Therapeutics IncOver The Counter Market:PNGM
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Er Therapeutics Inc | 5.8K | --- | --- |
Sovereign Lithium Inc | 50.0 | 0.0x | --- |
Goldrich Mining Co | 39.3K | 0.0x | --- |
MegumaGold Corp | 22.0K | 0.0x | --- |
Affinity Gold Corp | 50.0 | 0.0x | --- |
Diamond Holdings Inc | 2.8K | 0.0x | --- |
Company Information
Er Therapeutics, Inc., formerly Pengram Corporation (Pengram), is an exploration stage company. The Company has not realized any revenues from its planned operations. The Company is engaged in acquiring exploration and development of natural resource properties. The Company has not commenced business operations. The Company has interests in Clisbako claims and Eureka claims. The Company has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The Company also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.
Contact Information
- Headquarters
- 1200 Dupont St Ste 23BELLINGHAM, WA, United States 98225-3100
- Phone
- 360-255-3436
- Fax
- ---
Executives
- President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
- Richard Donaldson
- Director
- Howard Metzler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.8K |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 58.3M |
Er Therapeutics Inc does not pay a dividend. | |
Beta | --- |
EPS | --- |
Book Value | $0.00 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
